Merck & Co. - Vioxx

Modified on 2009/10/14 21:49 by admin
Securities fraud linked to the arthritis medication Vioxx has led plaintiff attorneys to file a class action lawsuit against pharmaceutical maker Merck & Co., Inc and several of the company's top officers. In November 2003, an amended complaint was filed in the United States District Court for the Eastern District of Louisiana on behalf on all investors who bought common stock in Merck between May 1999 and October 2003.

According to the complaint, Merck, through quarterly and annual reports and numerous press releases, mislead investors as to the true extent of the company's financial gains. Merck allegedly failed to disclose major concerns that company scientists had over Vioxx, including its link to cardiovascular disease. Company directors also failed to properly notify investors of how personal injury and wrongful death lawsuits filed over Vioxx would affect future earnings.

If you have been victimized by securities fraud because of Merck, it may be important to contact an attorney who can help you protect your legal rights. Please keep in mind that there may be time limits within which you must commence suit.

Attorneys associated with will evaluate your case free of charge. In addition, you will not pay any fees unless your attorney recovers money for you. Please click on the free Ask An Attorney button to take advantage of this valuable service.

See Also

  1. Securities & Investment Fraud
  Name Size